Item(by='gr2zr4', descendants=None, kids=[25279510, 25275203], score=None, time=1606898499, title=None, item_type='comment', url=None, parent=25273925, text='This could be the fastes approval in the whole drugs&#x27; history considering that<p>The assessment of a marketing authorisation application for a new medicine takes up to 210 ‘active’ days. This active evaluation time is the time spent by EMA experts to evaluate the evidence provided by the applicant in support of a marketing authorisation application.<p>This time is interrupted by one or two ‘clock-stops’ during which the applicant prepares the answers to any questions raised by the CHMP. The maximum duration of a clock-stop depend on how long the applicant thinks it will take to respond, but must be agreed by the CHMP. The first clock-stop usually lasts 3 to 6 months and the second one 1 to 3 months.<p>Overall, the assessment of a new medicine usually lasts around a year.<p><a href="https:&#x2F;&#x2F;www.ema.europa.eu&#x2F;en&#x2F;human-regulatory&#x2F;marketing-authorisation&#x2F;evaluation-medicines-step-step" rel="nofollow">https:&#x2F;&#x2F;www.ema.europa.eu&#x2F;en&#x2F;human-regulatory&#x2F;marketing-auth...</a>')